Malignancy in patients with inflammatory myopathy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Rheumatology
Link
http://link.springer.com/content/pdf/10.1007/s11926-002-0087-9.pdf
Reference59 articles.
1. Stockton D, Doherty VR, Brewster DH: Risk of cancer in patients with dermatomyositis or polymyositis, and followup implications: a Scottish population-based cohort study. Br J Cancer 2001, 85:41–45. Like earlier population-based cohort studies, this study identified hospitalized patients with dermatomyositis/polymyositis from a national hospital registry, but did not verify diagnosis by chart review. The authors observed an increased risk of malignancy in dermatomyositis (over seven-fold) and polymyositis (about two-fold).
2. Buchbinder R, Forbes A, Hall S, et al.: Incidence of malignant disease in biopsy-proven inflammatory myopathy: a populationbased cohort study. Ann Intern Med 2001, 134:1087–1095. This study identified patients with biopsy-proven myositis from a centralized muscle pathology service thereby ensuring the legitimacy of the diagnosis and reducing the risk of misclassification of polymyositis and dermatomyositis. It verified that the risk of malignancy is increased in dermatomyositis (more than six-fold) and polymyositis (two-fold), especially in the first 3 years after myositis diagnosis. An increased risk of malignant disease in inclusion body myositis (over two-fold) was also observed.
3. Hill CL, Zhang Y, Sigurgeirsson B, et al.: Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001, 357:96–100. This study reported a pooled analysis of previously published Swedish, Danish, and Finnish data revealing an increased relative risk for ovarian, lung, colorectal, stomach, pancreas cancers and non-Hodgkin’s lymphoma in dermatomyositis and lung and bladder cancer and non-Hodgkin’s lymphoma in polymyositis.
4. Chen YJ, Wu CY, Shen JL: Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol 2001, 144:825–831. Factors found to be associated with malignancy in this study were older age at onset of myositis (> 45 years) and with men. Interstitial lung disease was associated with lower risk. These findings need to be interpreted cautiously as it is unclear whether the duration of followup and surveillance for cancer was similar in both groups. Nasopharyngeal carcinoma was the most common cancer associated with dermatomyositis in this study from Taiwan.
5. Villa AR, Kraus A, Jimenez-Corona A: Malignant neoplasms in autoimmune rheumatic diseases: examination of the risk of developing a malignancy among five rheumatic diseased in one institution. Clin Rheumatol 2000, 6:176–183.
Cited by 85 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neurological complications of GI cancers;Neurological Complications of Systemic Cancer and Antineoplastic Therapy;2022
2. Polymyositis and rhabdomyolysis caused by hepatocellular carcinoma - Case report and literature review;Annals of Medicine and Surgery;2021-05
3. Paraneoplastische Autoimmundermatosen;Der Hautarzt;2021-03-01
4. Overall and site-specific cancer before and after diagnosis of idiopathic inflammatory myopathies: A nationwide study 2002–2016;Seminars in Arthritis and Rheumatism;2021-02
5. The prevalence, clinical features, predictive factors and investigations to screen for cancer in patients with inflammatory myositis;Saudi Medical Journal;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3